XML 20 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Segment and Related Information (Tables)
3 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Schedule of Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense

Segment revenue and operating income (loss) were as follows during the periods presented:

 

 

 

Diagnostics

 

 

Other

 

 

Total

 

Three months ended September 30, 2019

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

170.4

 

 

$

15.9

 

 

$

186.3

 

Depreciation and amortization

 

 

16.9

 

 

 

1.3

 

 

 

18.2

 

Segment operating income (loss)

 

 

17.3

 

 

 

(38.2

)

 

 

(20.9

)

Three months ended September 30, 2018

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

189.0

 

 

$

13.3

 

 

$

202.3

 

Depreciation and amortization

 

 

17.0

 

 

 

1.3

 

 

 

18.3

 

Segment operating income

 

 

27.6

 

 

 

(26.4

)

 

 

1.2

 

 

 

 

Three months ended

 

 

 

September 30,

 

 

 

2019

 

 

2018

 

Total operating income for reportable segments

 

$

(20.9

)

 

$

1.2

 

Unallocated amounts:

 

 

 

 

 

 

 

 

Interest income

 

 

0.9

 

 

 

0.7

 

Interest expense

 

 

(2.9

)

 

 

(2.2

)

Other

 

 

0.6

 

 

 

1.1

 

Income (loss) from operations before income taxes

 

 

(22.3

)

 

 

0.8

 

Income tax provision

 

 

(1.7

)

 

 

1.6

 

Net income (loss)

 

 

(20.6

)

 

 

(0.8

)

Net loss attributable to non-controlling interest

 

 

 

 

 

(0.1

)

Net income (loss) attributable to Myriad Genetics, Inc.

   stockholders

 

$

(20.6

)

 

$

(0.7

)